Key result
Master@Heart evaluates whether lifelong endurance exercise reduces mixed coronary plaques compared to non-athletes.
Why the study?
The cardiovascular health benefits of strenuous and prolonged endurance exercise have been challenged, as higher exercise doses are associated with greater coronary atherosclerotic plaque burden, AF risk, and myocardial fibrosis.
Does lifelong endurance exercise compared to late-onset endurance exercise and a healthy non-athletic lifestyle alter the prevalence of mixed coronary plaques, atrial fibrillation, and myocardial fibrosis in men aged 45-70 years?
Cohort (n=600)
Random sampling stratified by current age and age at which endurance training was started (plus random selection of 210 subjects for CMR)
Yes
Does lifelong endurance exercise compared to late-onset endurance exercise and a healthy non-athletic lifestyle alter the prevalence of mixed coronary plaques, atrial fibrillation, and myocardial fibrosis in men aged 45-70 years?
This rationale and design paper outlines the Master@Heart study, which uses comprehensive multimodality cardiovascular phenotyping in men free of conventional cardiovascular risk factors to clarify the dose-response relationship between lifelong vs late-onset strenuous endurance training and coronary plaque composition, atrial fibrillation, and myocardial fibrosis.
Answers are grounded in this paper and cite their sources.
Effects of lifelong endurance exercise on mixed plaques and AF remain unresolved in low-risk men; Master@Heart leaves open the dose-response relationship.
INTRODUCTION: Low and moderate endurance exercise is associated with better control of cardiovascular risk factors, a decreased risk of coronary artery disease and atrial fibrillation (AF). There is, however, a growing proportion of individuals regularly performing strenuous and prolonged endurance exercise in which the health benefits have been challenged. Higher doses of endurance exercise have been associated with a greater coronary atherosclerotic plaque burden, risk of AF and myocardial fibrosis (MF). METHODS AND ANALYSIS: Master@Heart is a multicentre prospective cohort study aiming to assess the incidence of coronary atherosclerosis, AF and MF in lifelong endurance athletes compared to late-onset endurance athletes (initiation of regular endurance exercise after the age of 30 years) and healthy non-athletes.The primary endpoint is the incidence of mixed coronary plaques. Secondary endpoints include coronary calcium scores, coronary stenosis >50%, the prevalence of calcified and soft plaques and AF and MF presence. Tertiary endpoints include ventricular arrhythmias, left and right ventricular function at rest and during exercise, arterial stiffness and carotid artery intima media thickness.Two hundred male lifelong athletes, 200 late-onset athletes and 200 healthy non-athletes aged 45-70 will undergo comprehensive cardiovascular phenotyping using CT, coronary angiography, echocardiography, cardiac MRI, 12-lead ECG, exercise ECG and 24-hour Holter monitoring at baseline. Follow-up will include online tracking of sports activities, telephone calls to assess clinical events and a 7-day ECG recording after 1 year. ETHICS AND DISSEMINATION: Local ethics committees approved the Master@Heart study. The trial was launched on 18 October 2018, recruitment is complete and inclusions are ongoing. TRIAL REGISTRATION NUMBER: NCT03711539.
No takes yet. Share an insight, caveat, or question.
Bosscher et al. (2021) conducted a cohort in Cardiovascular pathology (coronary atherosclerosis, atrial fibrillation, myocardial fibrosis) in master endurance athletes (n=600). Lifelong endurance exercise (started before age 30) and late-onset endurance exercise (started after age 30) vs. Healthy non-athletic lifestyle (<=3 hours/week of physical activity without prior regular endurance exercise) was evaluated on Difference in the prevalence/incidence of mixed coronary plaques on CT coronary angiography. Master@Heart is an ongoing study of 600 men evaluating if lifelong endurance exercise reduces mixed coronary plaques compared to non-athletes.
Synapse has enriched 10 related papers. Consider them for comparative context: